Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics

Aptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic an...

Full description

Bibliographic Details
Main Authors: Baby Santosh, Pramod K. Yadava
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/540451
id doaj-eb469542ef2b4ab99d9d57e4d04daf02
record_format Article
spelling doaj-eb469542ef2b4ab99d9d57e4d04daf022020-11-24T23:05:21ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/540451540451Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and TherapeuticsBaby Santosh0Pramod K. Yadava1Applied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, IndiaApplied Molecular Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, IndiaAptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic and therapeutic applications. Although use of nucleic acid aptamers as targeted therapeutics or mediators of targeted drug delivery is a relatively new avenue of research, one aptamer-based drug “Macugen” is FDA approved and a series of aptamer-based drugs are in clinical pipelines. The present review discusses the aspects of design, unique properties, applications, and development of different aptamers to aid in cancer diagnosis, prevention, and/or treatment under defined conditions.http://dx.doi.org/10.1155/2014/540451
collection DOAJ
language English
format Article
sources DOAJ
author Baby Santosh
Pramod K. Yadava
spellingShingle Baby Santosh
Pramod K. Yadava
Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
BioMed Research International
author_facet Baby Santosh
Pramod K. Yadava
author_sort Baby Santosh
title Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
title_short Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
title_full Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
title_fullStr Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
title_full_unstemmed Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
title_sort nucleic acid aptamers: research tools in disease diagnostics and therapeutics
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2014-01-01
description Aptamers are short sequences of nucleic acid (DNA or RNA) or peptide molecules which adopt a conformation and bind cognate ligands with high affinity and specificity in a manner akin to antibody-antigen interactions. It has been globally acknowledged that aptamers promise a plethora of diagnostic and therapeutic applications. Although use of nucleic acid aptamers as targeted therapeutics or mediators of targeted drug delivery is a relatively new avenue of research, one aptamer-based drug “Macugen” is FDA approved and a series of aptamer-based drugs are in clinical pipelines. The present review discusses the aspects of design, unique properties, applications, and development of different aptamers to aid in cancer diagnosis, prevention, and/or treatment under defined conditions.
url http://dx.doi.org/10.1155/2014/540451
work_keys_str_mv AT babysantosh nucleicacidaptamersresearchtoolsindiseasediagnosticsandtherapeutics
AT pramodkyadava nucleicacidaptamersresearchtoolsindiseasediagnosticsandtherapeutics
_version_ 1725626089447882752